Avricore Health Inc (AVCR : TSX-V)
Common Stock
$0.06
CAD
-0.00 (-8.33%)
Last updated: 2026-07-16
AVCR
Avricore Health Inc
WealthAwesomePerformance
1 Day
-8.33%
1 Week
-15.38%
1 Month
+10.00%
YTD
+0.00%
Key Statistics
Market Cap
$7.58M
52W High
$0.10
52W Low
$0.04
P/E Ratio
-
50 Day MA
$0.06
200 Day MA
$0.06
Beta
0.32
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/16/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 58,500 |
| 7/14/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 23,000 |
| 7/13/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 21,000 |
| 7/10/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 25,600 |
| 7/9/2026 | $0.07 | $0.09 | $0.07 | $0.07 | $0.07 | 251,128 |
| 7/7/2026 | $0.06 | $0.07 | $0.06 | $0.06 | $0.06 | 6,115 |
| 7/6/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 5,000 |
| 7/2/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 2,000 |
| 6/30/2026 | $0.06 | $0.07 | $0.06 | $0.07 | $0.07 | 30,000 |
| 6/26/2026 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 20,000 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCR's historical volatility
30-Day Vol
136.8%
Annualized
90-Day Vol
113.2%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.05
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.05 | C$0.03 – C$0.08 |
| 60 trading days | C$0.05 | C$0.03 – C$0.10 |
| 90 trading days | C$0.05 | C$0.02 – C$0.10 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Avricore Health Inc
Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.
Financials
- Revenue (TTM)
- $144,138
- EBITDA
- $-1.29M
- Profit Margin
- 0.00%
- ROE (TTM)
- -184.99%
- EPS (Diluted)
- -0.02
- Book Value
- 0.00
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About AVCR
Articles Featuring AVCR.V
Latest articles and analysis covering AVCR.V
Why Avricore Health Inc stock is plummeting today
Avricore Health Inc's stock has taken a hit, dropping 8.33% in the last trading session, closing at CA$0.06. This decline comes amidst a backdrop of ambitious expansion plans but lacks recent news to provide context for the downturn.
Why Avricore Health Inc stock is plummeting today
Avricore Health Inc's stock plummeted by 14.29% today, closing at CA$0.06. This significant drop raises questions about the company's future amid ongoing expansion efforts in the UK.
Why Avricore Health Inc stock is skyrocketing today
Avricore Health Inc. shares jumped by 7.69% as the company ramps up its UK expansion plans for the HealthTab™ platform, signaling positive investor sentiment.
Why Avricore Health Inc stock is skyrocketing today
Avricore Health Inc has seen a significant uptick in its stock price today, driven by investor optimism surrounding its ongoing expansion efforts in the UK. As the company continues to develop its HealthTab™ platform, it may present lucrative opportunities for growth.
Why Avricore Health Inc stock is skyrocketing today
Avricore Health Inc's stock jumped by 16.67% in the last trading session, closing at CA$0.07. This surge has sparked interest among investors, who are eager to understand the factors behind this sudden movement.
Why Avricore Health Inc stock is skyrocketing today
Avricore Health Inc (AVCR.V) has experienced a significant 9.09% increase in its stock price, closing at CA$0.06. This rise is attributed to recent financing activities aimed at supporting the company's expansion plans, particularly in the UK market.
Why Avricore Health Inc stock is skyrocketing today
Avricore Health Inc. has experienced a significant stock price increase of 18.18%, driven by positive investor sentiment regarding its expansion plans and recent financial milestones.
Why Avricore Health Inc stock is plummeting today
Avricore Health Inc's stock has dropped 15.38% in a single trading day, raising concerns about its financial stability and growth prospects amidst recent funding activities.
Why Avricore Health Inc stock is plummeting today
Avricore Health Inc. has experienced a sharp decline in its stock price, closing at CA$0.06 after a 15.38% drop. Investors are left questioning the company's stability and future growth potential.
Why Avricore Health Inc stock is skyrocketing today
Avricore Health Inc. has seen its stock price soar by 18.18% today, fueled by strategic expansions and financing efforts aimed at enhancing its HealthTab™ platform in the UK.
Why Avricore Health Inc stock is skyrocketing today
Avricore Health Inc's stock has experienced a significant boost, climbing 18.18% in the last trading session. This increase is likely linked to the company's ongoing efforts to expand its HealthTab™ network and recent financing initiatives aimed at supporting these endeavors.
Why Avricore Health Inc stock is plummeting today
Avricore Health Inc's stock has dropped 8.33% in the last trading session, closing at CA$0.06. Investors are left wondering about the company's future as it navigates its expansion plans without recent positive news.
Why Avricore Health Inc stock is skyrocketing today
Avricore Health Inc's stock has surged by over 9% today, driven by investor optimism surrounding its expansion plans in the UK. The company recently closed a significant financing round, positioning it for growth.
What to Expect from Avricore Health Inc.'s Earnings Report on May 29
Avricore Health Inc. is gearing up for its earnings report on May 29, with investors eager to see how recent expansions impact its financial health.
